Our study indicated RSPO2 was significantly down-regulated in READ and kept the line with the published research, which demonstrates RSPO2 functions as a tumor suppressor; over-expression of it inhibits CRC cell proliferation and tumorigenicity [28]. This evidence concerns the gene RSPO2 and colorectal carcinoma.